Supplemental material
Open access
1,442
Views
1
CrossRef citations to date
0
Altmetric
Research Paper
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
Goran StevanovicClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaCorrespondence[email protected]
View further author information
, View further author information
Lidija LavadinovicClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information
, Svetlana Filipovic VignjevicDiagnostics and Research and Development, Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information
, Renée HoltCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information
, Katarina IlicDiagnostics and Research and Development, Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information
, Francesco Berlanda ScorzaCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information
, Erin SparrowUniversal Health Coverage and Health Systems, The World Health Organization, Geneva, SwitzerlandView further author information
, Vera StoiljkovicManaging Director of the Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, SerbiaView further author information
, Guido TorelliUniversal Health Coverage and Health Systems, The World Health Organization, Geneva, SwitzerlandView further author information
, Tamra MadenwaldCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information
, Muriel SocquetCenter for Vaccine Innovation and Access, PATH, Geneva, SwitzerlandView further author information
, Aleksandra BaracClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information
, Yordanka Ilieva-BorisovaComac Medical, Sofia, BulgariaView further author information
, Mijomir PelemisClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Faculty of Medicine University of Belgrade, Belgrade, SerbiaView further author information
& Jorge FloresCenter for Vaccine Innovation and Access, PATH, Seattle, WA, USAView further author information
show all
Pages 579-586
|
Received 26 Sep 2017, Accepted 03 Dec 2017, Published online: 23 Feb 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.